Practice Point Communications

Practice Point®: Rare Diseases

Education EN ↓ 46 episodes

In these podcasts, we dive deep into the world of rare diseases, where every story is unique and every diagnosis a challenge. The episodes highlight the personal journeys of patients and medical professionals as they navigate the complexities of rare conditions. Each episode features expert insights on cutting-edge research, emerging treatments, and the social and emotional aspects of living with a rare disease. These podcasts are your guide to understanding and advocating for those affected by these often misunderstood conditions.

Be sure to visit the podcast's website and support the creator: rss.com

Author

Practice Point Communications

Category

Education

Podcast website

rss.com

Latest episode

Nov 19, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 10M+ downloads · 4.7+ rating iOS soon

Episodes

Episode 21 - Rethinking Stroke Prevention: Addressing the Unmet Needs in Antithrombotic Therapy - Part 5 - Practical Considerations - How Will FXIa Inhibitors Fit Into Stroke Prevention? 25.08.2025

Stay informed on the go with our expert-led podcast series dedicated to stroke prevention. Across seven short episodes, Dr.'s C. Michael Gibson and Manesh Patel explore the shifting landscape of antithrombotic therapy—especially the potential role of Factor XIa inhibitors. From trial data to clinical applications, this series distills what you need to know to enhance patient care and reduce stroke...

Episode 20 - Rethinking Stroke Prevention: Addressing the Unmet Needs in Antithrombotic Therapy - Part 4 - Clinical Data Deep Dive - What Clinical Trials Tell Us 25.08.2025

Stay informed on the go with our expert-led podcast series dedicated to stroke prevention. Across seven short episodes, Dr.'s C. Michael Gibson and Manesh Patel explore the shifting landscape of antithrombotic therapy—especially the potential role of Factor XIa inhibitors. From trial data to clinical applications, this series distills what you need to know to enhance patient care and reduce stroke...

Episode 19 - Rethinking Stroke Prevention: Addressing the Unmet Needs in Antithrombotic Therapy - Part 3 - Understanding Residual Stroke Risk and the Consequences of Undertreatment 25.08.2025

Stay informed on the go with our expert-led podcast series dedicated to stroke prevention. Across seven short episodes, Dr.'s C. Michael Gibson and Manesh Patel explore the shifting landscape of antithrombotic therapy—especially the potential role of Factor XIa inhibitors. From trial data to clinical applications, this series distills what you need to know to enhance patient care and reduce stroke...

Episode 18 - Rethinking Stroke Prevention: Addressing the Unmet Needs in Antithrombotic Therapy - Part 2 - FXIa Inhibition - A New Paradigm in Stroke Prevention 25.08.2025

Stay informed on the go with our expert-led podcast series dedicated to stroke prevention. Across seven short episodes, Dr.'s C. Michael Gibson and Manesh Patel explore the shifting landscape of antithrombotic therapy—especially the potential role of Factor XIa inhibitors. From trial data to clinical applications, this series distills what you need to know to enhance patient care and reduce stroke...

Episode 17 - Rethinking Stroke Prevention: Addressing the Unmet Needs in Antithrombotic Therapy - Part 1 - The Unmet Needs in Stroke Prevention 25.08.2025

Stay informed on the go with our expert-led podcast series dedicated to stroke prevention. Across seven short episodes, Dr.'s C. Michael Gibson and Manesh Patel explore the shifting landscape of antithrombotic therapy—especially the potential role of Factor XIa inhibitors. From trial data to clinical applications, this series distills what you need to know to enhance patient care and reduce stroke...

Episode 16 - Neurofibromatosis Type 1-related Plexiform Neurofibromas: Key Advances from the 2025 Annual Oncology Conference (Chicago) 05.06.2025

The introduction of kinase inhibitors has significantly impacted the treatment landscape of plexiform neurofibromas (PN) associated with neurofibromatosis type 1 (NF1). In this podcast activity from the 2025 Annual Oncology Meeting, noteworthy data in NF1-PN has been summarized and evaluated by Dr. Amy Armstrong. This activity is AMA/ABS/ANCC/ACPE accredited for one-year. Launch Date: June 5, 2025...

Episode 15 - Clinical Clips from EASL Congress 2025: Key Breakthroughs in the Treatment of Primary Biliary Cholangitis - Part 2 13.05.2025

There continues to be significant progress in the treatment of primary biliary cholangitis (PBC) and these Clinical Clips from EASL 2025 have focused on the most impactful data presented at this conference. Dr. Nancy Reau will summarize key advances from Day 2 of EASL 2025 and describe their implications for clinical practice. Launch Date: May 13, 2025 Release Date: May 13, 2025 Expiration Date: A...

Episode 14 - Clinical Clips from EASL Congress 2025: Key Breakthroughs in the Treatment of Primary Biliary Cholangitis - Part 1 13.05.2025

There continues to be significant progress in the treatment of primary biliary cholangitis (PBC) and these Clinical Clips from EASL 2025 have focused on the most impactful data presented at this conference. Dr. Nancy Reau will summarize key advances from Day 1 of EASL 2025 and describe their implications for clinical practice. Launch Date: May 13, 2025 Release Date: May 13, 2025 Expiration Date: A...

Episode 13 - Emerging Evidence in Myasthenia Gravis: Key Updates from AAN 2025 30.04.2025

In this podcast titled "Emerging Evidence in Myasthenia Gravis: Key Updates from AAN 2025," Dr. Nicholas Silvestri provides healthcare professionals with an actionable update on recent advancements in MG; which features insights from groundbreaking research presented at AAN 2025. Launch Date: April 30, 2025 Release Date: April 30, 2025 Expiration Date: March 31, 2026 FACULTY Nicholas Silvestri, MD...

Episode 12 - Emerging Evidence in Myasthenia Gravis: A Special Edition Podcast Series - Part 4 The Future of MG Care: Innovations in Diagnostics and Guidelines 28.04.2025

Join Dr. Nicholas Silvestri in this 8-minute, special edition podcast series on myasthenia gravis (MG). Today’s podcast titled, The Future of MG Care: Innovations in Diagnostics and Guidelines , looks ahead at emerging technologies and the need for standardized international guidelines to harmonize MG management. Launch Date: April 28, 2025 Release Date: April 28, 2025 Expiration Date: March 31, 2...

Episode 11 - Emerging Evidence in Myasthenia Gravis: A Special Edition Podcast Series - Part 3 Tailoring Treatment: The Role of Serotype Testing 24.04.2025

Join Dr. Nicholas Silvestri in this 9-minute, special edition podcast series on myasthenia gravis (MG). Today’s podcast titled, Tailoring Treatment: The Role of Serotype Testing , discusses the impact of serotype testing on treatment decisions, including differences in therapeutic approaches for AChR-positive, MuSK-positive, and LRP4-positive patients. Launch Date: April 24, 2025 Release Date: Apr...

Episode 10 - Emerging Evidence in Myasthenia Gravis: A Special Edition Podcast Series - Part 2 Innovations in MG Therapeutics 21.04.2025

Join Dr. Nicholas Silvestri in this 10-minute, special edition podcast series on myasthenia gravis (MG). Today’s podcast titled, Innovations in MG Therapeutics , focuses on the latest therapies, including complement inhibitors and FcRn antagonists, and their application in personalized treatment plans. Launch Date: April 21, 2025 Release Date: April 21, 2025 Expiration Date: March 31, 2026 FACULTY...

Episode 9 - Emerging Evidence in Myasthenia Gravis: A Special Edition Podcast Series - Part 1 Advancements in Myasthenia Gravis Diagnosis 17.04.2025

Join Dr. Nicholas Silvestri in this 8-minute, special edition podcast series on myasthenia gravis (MG). Today’s podcast titled, Advancements in Myasthenia Gravis Diagnosis , highlights the limitations of traditional diagnostic methods and introduces emerging technologies such as high-sensitivity serotype testing and advanced neurophysiological techniques. Launch Date: April 17, 2025 Release Date:...

Episode 8 - Integrating Practice-Changing Updates to Improve Outcomes Among Patients 21.01.2025

Please refer to the activity landing page for the downloadable slides. Primary biliary cholangitis (PBC) is a chronic, cholestatic, autoimmune liver disease that can progress to end-stage liver disease. Recent developments have led to important updates in the diagnosis and use of novel approaches in treatment for patients with PBC. This podcast will utilize case-based discussion to address implica...

Episode 7 - Clinical Clips® from AASLD 2024: Key Breakthroughs in the Treatment of Primary Biliary Cholangitis - Part 2 21.01.2025

Several new developments in primary biliary cholangitis (PBC) on available and emerging therapies were presented at AASLD 2024. In these podcasts, Dr. Ashwani K. Singal will discuss the most important breakthroughs in the understanding and treatment of PBC and will provide guidance on their impact. Launch Date: November 26, 2024 Release Date: November 26, 2024 Expiration Date: October 31, 2025 FAC...

Episode 6- Clinical Clips® from AASLD 2024: Key Breakthroughs in the Treatment of Primary Biliary Cholangitis - Part 1 20.01.2025

Several new developments in primary biliary cholangitis (PBC) on available and emerging therapies were presented at AASLD 2024. In these podcasts, Dr. Ashwani K. Singal will discuss the most important breakthroughs in the understanding and treatment of PBC and will provide guidance on their impact. Launch Date: November 26, 2024 Release Date: November 26, 2024 Expiration Date: October 31, 2025 FAC...

Episode 5 - Patient Voices in Primary Biliary Cholangitis: A CE Podcast Series to Recognize Challenges, Reduce Disparities, and Improve Outcomes - Part 3: Woman with PBC Requiring 2nd-Line Therapy 20.01.2025

This podcast features an engaging discussion between Dr. Douglas Dieterich and his patient with long-standing PBC, on the patient’s insights and experiences with her disease and treatment. The activity will enable participants to understand the importance of listening to patient perspectives when designing individualized care pathways to alleviate symptoms and improve quality of life. Launch Date:...

Episode 4 - Patient Voices in Primary Biliary Cholangitis: A CE Podcast Series to Recognize Challenges, Reduce Disparities, and Improve Outcomes - Part 2: Comorbidities and PBC 20.01.2025

This podcast features an engaging discussion between Dr. David Victor and his patient, with long-standing PBC, on the patient’s insights and experiences with her disease and treatment. The activity will enable participants to understand the importance of listening to patient perspectives when designing individualized care pathways to alleviate symptoms and improve quality of life. Launch Date: Oct...

Episode 3 - Patient Voices in Primary Biliary Cholangitis: A CE Podcast Series to Recognize Challenges, Reduce Disparities, and Improve Outcomes - Part 1: Long-Standing PBC 20.01.2025

This podcast features an engaging discussion between Dr. Douglas Dieterich and his patient, a 54-year-old woman with long-standing PBC, on the patient’s insights and experiences with her disease and treatment. The activity will enable participants to understand the importance of listening to patient perspectives when designing individualized care pathways to alleviate symptoms and improve quality...

Episode 2 - Podcast from EASL Congress 2024: Key Breakthroughs in the Treatment of Primary Biliary Cholangitis - Part 2 20.01.2025

Several new developments in primary biliary cholangitis (PBC) on available and emerging therapies will be presented at the annual European Association for the Study of the Liver (EASL) 2024 Congress in Milan, Italy. In this podcast series, Dr. Kris Kowdley will discuss the most important breakthroughs in the understanding and treatment of PBC presented at the EASL Congress 2024 and will provide gu...

Episode 1 -Podcast from EASL Congress 2024: Key Breakthroughs in the Treatment of Primary Biliary Cholangitis - Part 1 20.01.2025

Several new developments in primary biliary cholangitis (PBC) on available and emerging therapies will be presented at the annual European Association for the Study of the Liver (EASL) 2024 Congress in Milan, Italy. In this podcast series, Dr. Kris Kowdley will discuss the most important breakthroughs in the understanding and treatment of PBC presented at the EASL Congress 2024 and will provide gu...

Listen to the Practice Point®: Rare Diseases podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.